Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca.
about
The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode networkWhen the endogenous hallucinogenic trace amine N,N-dimethyltryptamine meets the sigma-1 receptor.Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 yearsThe globalization of traditional medicine in northern peru: from shamanism to molecules.Recent advances in the neuropsychopharmacology of serotonergic hallucinogensMetabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuascaAcute Biphasic Effects of AyahuascaBehavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine.Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers.Improving the oral bioavailability of beneficial polyphenols through designed synergies.Pharmahuasca: human pharmacology of oral DMT plus harmine.Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine.Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in ratsThe alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro.Methodology for determining major constituents of ayahuasca and their metabolites in blood.Reassessing the cultural and psychopharmacological significance of Banisteriopsis caapi: preparation, classification and use among the Piaroa of Southern Venezuela.Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors.The hallucinogenic world of tryptamines: an updated review.Neuropharmacology of N,N-dimethyltryptamineClinical applications of hallucinogens: A review.Traditional medicine in the treatment of drug addiction.The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs.Behavioral effects of α,α,β,β-tetradeutero-5-MeO-DMT in rats: comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitorBringing natural products into the fold - exploring the therapeutic lead potential of secondary metabolites for the treatment of protein-misfolding-related neurodegenerative diseases.Analytical techniques for the determination of tryptamines and β-carbolines in plant matrices and in psychoactive beverages consumed during religious ceremonies and neo-shamanic urban practices.Health status of ayahuasca users.Natural product 'legal highs'.A critical evaluation of reports associating ayahuasca with life-threatening adverse reactions.Behavioral Changes Over Time Following Ayahuasca Exposure in ZebrafishTherapeutic Applications of Classic Hallucinogens.Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies.New World Tryptamine Hallucinogens and the Neuroscience of Ayahuasca.The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging.A Model for the Application of Target-Controlled Intravenous Infusion for a Prolonged Immersive DMT Psychedelic Experience.Yopo, ethnicity and social change: a comparative analysis of Piaroa and Cuiva yopo uset.Biochemistry and pharmacology of tryptamines and beta-carbolines. A minireview.Discovery of 3-Hydroxy-3-phenacyloxindole Analogues of Isatin as Potential Monoamine Oxidase Inhibitors.In vitro and in vivo activities of Peganum harmala extract against Leishmania major.Assessing the Psychedelic "After-Glow" in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities.Evaluation of Antioxidant Activity, Total Flavonoids, Tannins and Phenolic Compounds in Psychotria Leaf Extracts.
P2860
Q21131813-55BEB4C6-B50D-406E-BDE1-E7B759079874Q24617727-31E39DEA-5356-4A4D-9495-BD0A90F99933Q26746137-7D203DBD-9DEF-4592-8AD4-A072389147C8Q26830049-60C7E251-855B-4FF4-81EF-9AB26E45CB93Q27027381-7722D59E-DCB5-4BCB-B152-3135F6D03AD5Q28264811-B0A8679D-6969-456D-A35F-EE597E8BC1B4Q28548629-A69286F2-0E40-40BE-BE9B-D0F37EC91E8DQ30358201-7409F385-36AC-4330-9A86-AEF785A7DB14Q30498444-12ECB7A0-D537-4DD6-AFCB-064B53F03C82Q33646033-8693C4FC-389D-4EBE-9B2F-090ADEF363EBQ33705905-2D7CD33A-7CAC-498C-BB5F-7629AF540172Q33740814-8772E728-931E-4561-8A68-956E50EC9C5DQ33833054-9D93343E-39B2-466C-8C6D-3B37E1ACBBA6Q33902992-A2512B5F-EAB2-416A-BF48-7F8414DA865EQ33944518-3B6E69BE-8EFC-4C9E-9B85-FDC3CE0AF759Q34014623-863E9965-B92F-4046-9AD4-6861184ED0BCQ34087847-D3B3A442-1EA8-41F5-835F-C20FDC429D1BQ34471834-9F087398-B80D-46C4-8497-717855488F56Q34524116-CF1243FA-C761-4906-8B39-A30E6AE38482Q34535259-C013255B-1CE9-4246-BF0D-703A08FE19D2Q34603231-8D75B0AB-B960-409F-ADF6-07B55E8EC4C8Q34660497-4391ABDB-422D-4AB4-9237-235D7DF3D584Q37230473-A8B2D5DB-A3A7-431C-996F-16002C91253DQ37798463-88B38545-9D1F-4035-B8B8-9B074DF901B4Q38009283-79BDF375-F06E-41F0-9A28-174D24A9F811Q38023821-9852ACD2-08C6-49AF-AAA6-68FB5EDE8CF0Q38038819-67DAF3C3-EE58-443F-B9A5-4271867E8DE1Q38126030-EB1D5CC9-EE8F-44CD-A7D0-AE765A0DDD09Q38626654-B49CE431-D7EA-46CB-8D29-8BAB48102A2FQ38781678-89CE0E65-63CB-479A-B7D9-761A50853E5BQ38816768-05DA5398-B724-4C9F-B3D0-0EBF5F0B58F6Q38841127-6AE536E2-B607-4378-AB91-76B79443B708Q38861685-D379DC30-B403-4D2B-B88E-0AB5F33AC520Q39546691-DE097D8C-B024-47F6-9718-1AB0D2C7AE79Q39746246-59CE7CCA-40E9-403F-96BC-F0FEFB2CCDBBQ40199366-EB75F7C9-CE32-4DDD-9ABE-1AF5AFC50AB4Q40291145-2E856D8A-3A42-46D8-913D-1FCD1FF78413Q40564060-04C1B3DC-B35C-4878-9E31-CBA51405263DQ41595323-8BAE3450-DA99-4DB7-9B5A-65D36A5818BFQ41896730-ECD91883-B12E-4455-8858-48F04D7CA004
P2860
Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca.
description
1984 nî lūn-bûn
@nan
1984 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Monoamine oxidase inhibitors i ...... ine constituents of ayahuasca.
@ast
Monoamine oxidase inhibitors i ...... ine constituents of ayahuasca.
@en
Monoamine oxidase inhibitors i ...... ine constituents of ayahuasca.
@nl
type
label
Monoamine oxidase inhibitors i ...... ine constituents of ayahuasca.
@ast
Monoamine oxidase inhibitors i ...... ine constituents of ayahuasca.
@en
Monoamine oxidase inhibitors i ...... ine constituents of ayahuasca.
@nl
prefLabel
Monoamine oxidase inhibitors i ...... ine constituents of ayahuasca.
@ast
Monoamine oxidase inhibitors i ...... ine constituents of ayahuasca.
@en
Monoamine oxidase inhibitors i ...... ine constituents of ayahuasca.
@nl
P2093
P1476
Monoamine oxidase inhibitors i ...... ine constituents of ayahuasca.
@en
P2093
P304
P356
10.1016/0378-8741(84)90003-5
P577
1984-04-01T00:00:00Z